BeiGene CEO and leadership

Vivian Xin is a Co-Chief Commercial Officer:Marketing at BeiGene Ltd. She has worked as Senior VP/Chief Commercial Ofcr at BeiGene Ltd and VP:Innovative at Xian Janssen Pharmaceutical. Vivian studied at Jilin University and CHINESE ACADEMY OF SCIENCES.

Wendy Yan is a SVP, Chief Regulatory Officer at BeiGene Ltd.

Michael Schoen joined BeiGene in 2017 and serves as Chief of Staff to CEO John Oyler and Senior Vice President, Business Operations.

Prior to joining BeiGene, he was Managing Director & Head of Latin America & Caribbean Debt Capital Markets for Scotiabank. Mr. Schoen additionally held leadership roles at Credit Suisse, DLJ, and J.P. Morgan in their respective Emerging Markets groups.

Mr. Schoen serves as Chairman of the Board of Directors for the HealthCare Chaplaincy Network, a global healthcare nonprofit organization that offers spiritual care-related resources and professional chaplaincy services in healthcare settings and online. He holds a B.S. in management from Massachusetts Institute of Technology’s Sloan School of Management.

Xiaobin Wu are a President, Chief Operating Officer, and General Manager of China at BeiGene Ltd.

Angus Grant joined Celgene as Vice President North American Regulatory Affairs in 2006, in the Summit NJ Headquarters. In 2008, Angus moved to London as Head of Europe RA for 3 years. Angus returned to the Summit NJ Headquarters as VP, Business Development and Global Alliances, in 2011, where he has since completed multiple innovative deals and has in tandem built the Alliance Management function, which now manages over 50 collaborations and investments with pharmaceutical and biotech partners. Prior to joining Celgene, Angus held positions as Executive Director for Alliance Management for Novartis Oncology, and positions of increasing responsibility in Regulatory Affairs for Merck KGaA/EMD, Rhone-Poulenc Rorer, and SmithKline Beecham Pharmaceuticals. Prior to working in industry, Angus served as a Senior Staff Fellow at the U.S. Food and Drug Administration Center for Biologics, and conducted his post-doctoral research in immunotherapy at the National Cancer Institute. Angus received his Ph.D. in Anatomy & Immunology from the Medical College of Virginia.

Vivian Xin is a Co-Chief Commercial Officer:Marketing at BeiGene Ltd. She has worked as Senior VP/Chief Commercial Ofcr at BeiGene Ltd and VP:Innovative at Xian Janssen Pharmaceutical. Vivian studied at Jilin University and CHINESE ACADEMY OF SCIENCES.

Xiaobin Wu are a President, Chief Operating Officer, and General Manager of China at BeiGene Ltd.